Discontinued — last reported Q2 '18
Eli Lilly Raw materials increased by 7.8% to $3.40B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 51.8%, from $2.24B to $3.40B.
Higher levels suggest preparation for increased production or a buffer against supply chain disruption, while lower levels may indicate lean operations or supply shortages.
This represents the value of basic materials and supplies held by the company that have not yet entered the production o...
Standard across all manufacturing and energy sectors; peers report this as a core component of working capital.
inv_raw_materials| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $1.63B | $1.69B | $1.88B | $2.24B | $2.33B | $2.69B | $3.15B | $3.40B |
| QoQ Change | — | +3.9% | +10.8% | +19.2% | +4.0% | +15.5% | +17.3% | +7.8% |
| YoY Change | — | — | — | — | +42.7% | +58.6% | +68.0% | +51.8% |
| % of Inventories | 28.2% | 28.2% | 29.3% | 30.3% | 30.6% | 29.0% | 28.6% | 27.8% |
| Share Change | — | -0.0pp | +1.1pp | +0.9pp | +0.4pp | -1.7pp | -0.3pp | -0.8pp |
We use cookies for analytics. See our Privacy and Cookie Policy.